Pharmaceutical products and services in healthcare, focusing on innovation and therapeutic solutions in India.
Annual revenue $72,179 Latest available
Total funding - Funding intelligence
Employees 6 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About NACC Pharmaceutical

NACC Pharmaceutical is a company. The company has 6 employees as of April 06, 2024. NACC Pharmaceutical offers products and services including Hypertension Drugs and Diabetes Drugs.

  • Employees 6 as on 06 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Nacc Pharmaceutical Pvt. Ltd
  • Jurisdiction Bangalore, Karnataka, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $72.18 K (USD)
    84.02
    as on Mar 31, 2023
  • Net Profit
    $2.64 K (USD)
    130.06
    as on Mar 31, 2023
  • EBITDA
    $5.65 K (USD)
    167.76
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    6

    as on Apr 06, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of NACC Pharmaceutical

NACC Pharmaceutical offers a comprehensive portfolio of products and services, including Hypertension Drugs and Diabetes Drugs.

Product name locked
Category locked
Primary

Drugs for hypertension are developed and distributed across various dosage forms.

Product name locked
Category locked
Locked

Medications for diabetes are provided as part of the therapeutic portfolio.

Funding Insights of NACC Pharmaceutical

Premium access

Detailed funding history for NACC Pharmaceutical

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by NACC Pharmaceutical

Investments
Premium access

Investment portfolio details for NACC Pharmaceutical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - NACC Pharmaceutical

Premium access

Detailed financials for NACC Pharmaceutical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Nacc Pharmaceutical Comparisons

NACC Pharmaceutical Primary company
Description
Pharmaceutical products and services in healthcare, focusing...
Location
-
Founded Year
-
Annual Revenue
$72.18 K (USD)
Net Profit
$2.64 K (USD)
EBITDA
$5.65 K (USD)
Employees
6
As of 2024
Premium access

Peer comparison for NACC Pharmaceutical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of NACC Pharmaceutical

Premium access

Detailed competitors of NACC Pharmaceutical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Nacc Pharmaceutical

Premium access

Complete news archive for NACC Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NACC Pharmaceutical

As of Apr 06, 2024, the latest employee count at NACC Pharmaceutical is 6.

Annual revenue of NACC Pharmaceutical is $72.18K as on Mar 31, 2023.

NACC Pharmaceutical Pvt. Ltd. is identified as a leading healthcare entity with a global presence, where products for hypertension, diabetes, and neurology are offered to enhance quality of life. The companys portfolio is expanded across multiple therapeutic areas and dosage forms, with research and development efforts being directed towards addressing unmet medical needs in India. Innovation is integrated through advanced manufacturing and a strong sales team, while a culture of customer service is maintained to position it as a major player in the pharmaceutical market. Holistic expertise is utilized to aim for excellence in the industry.

NACC Pharmaceutical offers Hypertension Drugs and Diabetes Drugs.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available